AGM/EGMNov 3, 2026, 05:22 PM
Vicore Pharma Announces Nomination Committee for 2027 AGM
AI Summary
Vicore Pharma Holding AB has announced the composition of its Nomination Committee for the upcoming 2027 Annual General Meeting (AGM), scheduled for May 5, 2027. The committee comprises representatives from the company's three largest shareholders as of August 31, 2026, along with Vicore's chairman. The committee's responsibilities include preparing proposals for board elections, auditor appointments, and setting rules for the subsequent year's nomination committee. Shareholders have until January 15, 2027, to submit any comments or proposals.
Key Highlights
- Vicore Pharma Holding AB announced the composition of its Nomination Committee for the 2027 Annual General Meeting (AGM).
- The committee includes members appointed by the three largest shareholders as of August 31, 2026.
- Staffan Lindstrand (HealthCap VII L.P.), Jan Särlvik (Fourth Swedish National Pension Fund), and Ivo Staijen (HBM Healthcare Investments) are appointed members.
- Vicore's chairman, Hans Schikan, will also serve as a member and convener.
- The Nomination Committee's tasks include preparing proposals for board elections, fees, auditor, and rules for the 2028 Nomination Committee.
- The 2027 AGM is scheduled for May 5, 2027.
- Shareholders can submit comments or proposals to the Nomination Committee by January 15, 2027.
Price Impact
More from VCRE